AKBA vs NSC · rev $102.7M vs P/E 18, rev $6.46B
Akebia Ther (AKBA) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
AKBA currently screens at market cap $260.1M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the AKBA and NSC stock pages for the full models.
Not investment advice.